semaglutide resistance for Insulin & Weight Loss Semaglutide: Double-edged Sword with Risks

Triple Hormone-Receptor Agonist Retatrutide for Obesity: A Phase 2 Trial

We need to do research to understand why these drugs work beyond weight loss

This makes it highly effective for preventing estrogenic side effects like gynecomastia, bloating, and water retention

The degree of gastric slowing correlates with early nausea, the most common side effect reported in SURPASS-1 through SURPASS-5 at nausea rates of 12 to 18% depending on dose [14]

For example, we saw significant ETD among patients aged 70+

The competitive landscape is marked by a mix of established players and emerging biotech firms, fostering innovation